Catalyst Wire Dossier Catalyst Wire Dossier

Kylo-0603

· Kylonova (Xiamen) Biopharma co., LTD.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kylo-0603, covering 2024-10-09 to 2024-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation Study of Kylo-0603 in Healthy Subjects [Phase 1]

See pricing